SAN DIEGO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (NASDAQ: SKYE) (“Skye” or the “Company”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today reported financial results for the second quarter ended June 30, 2024, and highlighted recent corporate achievements.
Skye Bioscience Reports Second Quarter 2024 Financial Results and Recent Highlights
SKYE BIOSCIENCE INC
NASDAQ:SKYE (2/11/2025, 8:00:01 PM)
Premarket: 2.65 -0.24 (-8.3%)2.89
-0.54 (-15.74%)
SKYE Latest News and Analysis
14 hours ago - ChartmillTuesday's session: top gainers and losersIntrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
